Mesa Laboratories (MLAB) Common Equity (2011 - 2025)

Mesa Laboratories has disclosed Common Equity across 15 years of filings, most recently posting $186.7 million for Q4 2025.

• Common Equity for Q4 2025 came in at $186.7 million, up 20.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $186.7 million (up 20.28% YoY), and the FY2025 annual result was $159.8 million, up 9.93% from the prior year.
• Common Equity came in at $186.7 million for Q4 2025 at Mesa Laboratories, up from $178.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $406.2 million in Q1 2021 to a low of $145.4 million in Q1 2024.
• The 5-year median for Common Equity is $383.8 million (2022), against an average of $300.9 million.
• Across the five-year window, Common Equity jumped 84.64% in 2021 and plunged 63.05% in 2024, its largest moves.
• Mesa Laboratories' Common Equity stood at $396.3 million in 2021, then fell by 2.3% to $387.2 million in 2022, then increased by 4.07% to $403.0 million in 2023, then plunged by 61.48% to $155.2 million in 2024, then increased by 20.28% to $186.7 million in 2025.
• The last three Common Equity figures came in at $186.7 million (Q4 2025), $178.5 million (Q3 2025), and $172.5 million (Q2 2025), per Business Quant data.